Skip to main content
. 2014 Sep 12;21(6):845–852. doi: 10.1530/ERC-14-0258

Table 1.

Univariate analysis: related variables with thyroid cancer for all patients enrolled in the study

Variable No cancer n (%)/mean (s.d.) (N=1790) Cancer n (%)/mean (s.d.) (N=233) P value
Age (mean/s.d.) 49.05 (15.93%) 45.33 (15.29%) 0.0007
N (%)
Female 1503 (83.97%) 190 (81.55%) 0.3467
Elevated TgAb 182 (10.17%) 48 (20.6%) <0.0001
Elevated TPOAb 478 (26.7%) 73 (31.33%) 0.1356
Euthyroid normal antibodies 935 (52.23%) 114 (48.93%) 0.3419
Hyperthyroid 189 (10.56%) 18 (7.73%) 0.1795
Hypothyroid 516 (28.83%) 72 (30.9%) 0.5118
MNG gland 1502 (83.91%) 188 (80.69%) 0.2119
Single nodule gland 288 (16.09%) 45 (19.31%) 0.2119
Thyroid medication 508 (28.43%) 69 (29.61%) 0.7062
History of head/neck radiation 24 (1.37%) 6 (2.59%) 0.1556
Family history of TC 90 (5.03%) 18 (7.73%) 0.2263